Navigation Links
Ampio forms Luoxis Diagnostics to Commercialize ORP Technology
Date:2/11/2013

GREENWOOD VILLAGE, Colo., Feb. 11, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company focused on developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (OA) and diabetic macular edema (DME), announced the incorporation and initiation of operations of Luoxis Diagnostics, a subsidiary of Ampio that will initially be funded through a private placement, with Ampio maintaining approximately 80% ownership post financing. Josh Disbrow , Ampio's Chief Operating Officer, will assume the role of Chief Executive Officer of Luoxis.  Details about the private placement will follow in the near future.

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

Ampio Chairman and Chief Executive Officer, Michael Macaluso , noted "The Oxidation Reduction Potential (ORP) diagnostic device and its patent portfolio has been "carved out" to become the lead asset of Luoxis Diagnostics, an in-vitro diagnostics company focused on the development and commercialization of diagnostics utilizing the company's ORP technology platform to indicate disease severity and progression across a wide range of critical and chronic illnesses. The ORP platform is a valuable asset in which the development of the "point-of-care" reader and disposable testing strips have been completed and multiple clinical trials with stored blood samples from patients with various diseases are underway.  Luoxis now needs its own management and financing to launch a comprehensive effort to assure the success of its commercial launch."

Mr. Disbrow, Luoxis's CEO, further explained the strategy "Ampio is a pharmaceutical company mainly focused on treatments for inflammatory diseases.
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Ampio Pharmaceuticals Schedules 2012 Update Webcast
4. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
5. Ampios CEO and CSO Send Message to Shareholders
6. Ampio Pharmaceuticals Announces Proposed Public Offering
7. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
8. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
9. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
10. Ampio Pharmaceuticals Announces Closing of Public Offering
11. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Dipexium ... pharmaceutical company focused on the development and commercialization ... new Locilex® microbiology data will be presented at ... Antimicrobial Agents and Chemotherapy and International Society of ... 2015) scientific meeting in San Diego, ...
(Date:7/28/2015)... , July 28, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an underwritten public offering of 6,666,667 shares ... price of $11.25 per share. The gross proceeds ... be approximately $75 million, before deducting the underwriting ...
(Date:7/28/2015)... Texas , July 28, 2015  ULURU Inc. (OTCQB: ... of Stockholders and the appointment of Bradley J. Sacks ... The Company,s Board of Directors has determined that the 2015 ... September 25, 2015 at 10:00 a.m., Central Daylight Time at ... Addison, TX 75001. In accordance with ...
Breaking Medicine Technology:Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 2ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors 3
... 10 years, Mark Wentland, professor of chemistry and chemical biology ... in the discovery of a family of novel opioid receptor ... addiction. The family of compounds was licensed to Alkermes Inc., ... library. Clinical trials with the candidate, known as ALKS 33, ...
... PARSIPPANY, N.J., May 8 Daiichi Sankyo, Inc. announced today ... Inc. (ASH) Annual Scientific Meeting and Exposition (ASH 2009) in ... BENICAR (R) and BENICAR HCT (R) provided a ... 25.7 mm Hg among patients with an average age of ...
Cached Medicine Technology:One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 2One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 3One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 4One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 5One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials 6New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 2New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 3New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 4New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 5New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 6New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 7New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure 8
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have increased by ... recent statistic Orlando suffers at least one death weekly as a direct result of ... enforcement officials are struggling to keep apace with its distribution. Officers rely on inside ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... SmileCareClub Invisible Aligner System to its online product offerings, giving its ... a teledentistry model and cloud-based technology, SmileCareClub allows patients to get quality, remote ...
(Date:7/28/2015)... ... 28, 2015 , ... A new Taiwanese study suggests that ... in the general population. Surviving Mesothelioma has just posted an article detailing the ... Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated the health records ...
(Date:7/28/2015)... ... 28, 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta ... Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized ... peers in the metro area as one of the most respected doctors in Reproductive ...
(Date:7/28/2015)... ... 28, 2015 , ... A June 3, 2015 article ... Injury" discussed baseball player David Wright’s spinal stenosis injury and his chances of ... by degenerative changes in the spine, rather than congenital, which is good news ...
Breaking Medicine News(10 mins):Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3
... standard precautions, nearly all children with known or suspected ... team of vaccine safety experts led by the Johns ... Pediatrics, the multicenter research team offers pediatricians ... reactions to vaccines, and a much-needed guide, they say, ...
... an increased risk for bipolar disorder in their offspring, ... Archives of General Psychiatry , one of the ... mood disorder involving episodes of mania and depression, according ... family history of psychotic disorders, few risk factors for ...
... calories per minute playing an active video game than ... also significantly higher with the active game, according to ... of Pediatrics & Adolescent Medicine , one of the ... becoming the preferred leisure-time activity for school-aged children, according ...
... Stahl to Moderate Panel With Huckabee, Thompson, Clegg in ... Gary Foster,President of The Obesity Society applauded the GOP ... epidemic is leading,to new strategies at the national and ... problem. We hope that these events shine a spotlight ...
... have evacuated more than 3,100 passengers from the Gulf Coast in ... Force Reserve and commercially-contracted flights. , ... (Vocus) September ... evacuated more than 3,100 passengers from the Gulf Coast in preparation ...
... The California,Nurses Association/National Nurses Organizing Committee today hailed ... style bill that would guarantee quality health care for ... national healthcare reform,debate that is sure to emerge in ... Kuehl, passed its final,legislative hurdle with a vote in ...
Cached Medicine News:Health News:Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say 2Health News:Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say 3Health News:Children of older fathers more likely to have bipolar disorder 2Health News:Children's calorie expenditure, heart rate increase during active video games 2Health News:Children's calorie expenditure, heart rate increase during active video games 3Health News:The Obesity Society Hails Republican Platform; Forum Set for Sept. 2 to Continue as Planned 2Health News:Air Force Hurricane Gustav Support 2Health News:Calif. Nurses Laud Passage of Single-Payer, SB 840, Seen as National Model for Guaranteed Healthcare for All 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: